Sugi Predict

Sugi Predict / Compounds / SCHEMBL3564256

SCHEMBL3564256

SCHEMBL3564256

COc1ccccc1-c1cn(S(=O)(=O)c2ccc(C)cc2)c2ncc(-c3ccc(N)c(C(=O)N4CCN(C)CC4)c3)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 1/20 0.43
▸ MAP4K1 Q92918 2/20 0.42
▸ MAPT P10636 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ CCKAR P32238 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ KCNH2 Q12809 2/20 0.39
▸ CCNE2 O96020 2/20 0.39
▸ CCNE1 P24864 2/20 0.39
▸ CDK2 P24941 2/20 0.39
▸ GSK3B P49841 2/20 0.39
▸ MAP4K4 O95819 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3565043 0.92 BTK (0.42) PTPN11MAP4K1MAPTTSHRSMN1; SMN2
SCHEMBL13342637 0.88 PTPN11 (0.51) PTPN11MAP4K1MAPTTSHRSMN1; SMN2
SCHEMBL3565148 0.86 MAP4K1 (0.59) PTPN11MAP4K1MAPTTSHRSMN1; SMN2
SCHEMBL13342638 0.85 ALDH1A1 (0.41) PTPN11TSHRMEN1KMT2ACCNE2
SCHEMBL3561085 0.85 PTPN11 (0.44) PTPN11MAP4K1MAPTTSHRSMN1; SMN2
Trifluoroacetic Acid SCHEMBL3560130 0.84 PTPN11 (0.47) PTPN11MAP4K1MAPTTSHRSMN1; SMN2
SCHEMBL3560133 0.83 PTPN11 (0.43) PTPN11MAP4K1MAPTTSHRSMN1; SMN2
SCHEMBL13368497 0.82 MAPT (0.47) PTPN11MAP4K1MAPTTSHRSMN1; SMN2
SCHEMBL3414082 0.82 TSHR (0.46) PTPN11MAP4K1MAPTTSHRSMN1; SMN2
SCHEMBL1516627 0.81 PTPN11 (0.47) PTPN11MAP4K1MAPTTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709645-B2 Pyrrolo-pyridine kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-05-04 — — US disclosed
US-7709645-B2 Pyrrolo-pyridine kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-05-04 — — US disclosed
US-7709645-B2 Pyrrolo-pyridine kinase modulators SGX PHARMACEUTICALS, INC. (US) 2010-05-04 — — US disclosed
EP-2134343-A2 PYRROLO-PYRIDINE KINASE MODULATORS SGX Pharmaceuticals, Inc. (US) 2009-12-23 — — EP disclosed
US-20090143352-A1 PYRROLO-PYRIDINE KINASE MODULATIORS SGX PHARMACEUTICALS, INC. (US) 2009-06-04 — — US disclosed
US-20090143352-A1 PYRROLO-PYRIDINE KINASE MODULATIORS SGX PHARMACEUTICALS, INC. (US) 2009-06-04 — — US disclosed
US-20090143352-A1 PYRROLO-PYRIDINE KINASE MODULATIORS SGX PHARMACEUTICALS, INC. (US) 2009-06-04 — — US disclosed
WO-2008124849-A2 PYRROLO-PYRIDINE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2008-10-16 — — WO disclosed
WO-2008124849-A2 PYRROLO-PYRIDINE KINASE MODULATORS SGX PHARMACEUTICALS, INC. (US) 2008-10-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143352-A1 PYRROLO-PYRIDINE KINASE MODULATIORS MAP4K2, PDXK, MAP4K1 PTPN11 1303/4885MAP4K1 3/4885MAPT 1385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.